Chang VC, Rhee J, Berndt SI, Moore SC, et al. Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer 2023 Feb 26. doi: 10.1002/ijc.34487.
PMID: 36843273